Naert et al. developed a fast preclinical model of RB by simply inducing an RB1 knockout via the CRISPR-Cas9 system for the induction of RB1 and retinoblastoma-like 1 (RBL1) knockout Xenopus tropicalis [154]. Here, RBL1 is linked to retinoblastoma.